Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-22 · accession 0001104659-23-094406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-23 | 2023-08-22 | NRXP | Javitt Jonathan C | Chief Scientist, Dir, 10% | P - Purchase | $0.32 | +200.0K | 346.3K | +137% | +$64.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-22 | P | A | 200,000 | $0.32 | 346,332 | D | — | — |